Cvs Health Stock News

Simon Quick Advisors LLC lowered its position in CVS Health Co. (NYSE:CVS) by 12.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,490 shares of the pharmacy operators stock after selling 205 shares during the period. Simon Quick Advisors LLCs holdings in CVS Health []

Livforsakringsbolaget Skandia Omsesidigt cut its position in CVS Health Co. (NYSE:CVS) by 5.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 55,253 shares of the pharmacy operators stock after selling 3,200 shares during the period. Livforsakringsbolaget Skandia Omsesidigts holdings in CVS Health were worth $4,687,000 []

PHILADELPHIA Stan Johnson Co., an Oklahoma-based brokerage firm specializing in net-leased retail assets, has negotiated the $10.8 million sale of a 12,485-square-foot retail condo in Philadelphia that is leased [] The post Stan Johnson Co. Negotiates $10.8M Sale of Philadelphia Retail Condo Leased to CVS appeared first on REBusinessOnline .

CVS Health Co. (NYSE:CVS) Analysts at Truist Securiti boosted their FY2021 earnings per share (EPS) estimates for shares of CVS Health in a research report issued on Tuesday, December 14th. Truist Securiti analyst D. Macdonald now forecasts that the pharmacy operator will post earnings of $8.02 per share for the year, up from their []

Related Stocks: CI , WERN , LSTR , FDX , CADE , CADE , SSB , IPG , CVS , ABBV , TROW , ABC , TSN , PFE , NTRS , CAH , ORCL , DOX ,

The firm also reduced a number of holdings in the 3rd quarter Check out Ronald Muhlenkamp Stock Picks » Download GuruFolio Report of Ronald Muhlenkamp (Updated on 12/13/2021) Related Stocks: EQC , BIIB , NVTA , CCJ , MTZ , BMY , BRK.B , MSFT , CVS , SLB ,

Keating Investment Counselors Inc. reduced its stake in shares of CVS Health Co. (NYSE:CVS) by 1.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 107,653 shares of the pharmacy operators stock after selling 1,895 shares during the quarter. CVS Health makes up []

Mercer Capital Advisers Inc. decreased its position in shares of CVS Health Co. (NYSE:CVS) by 33.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,000 shares of the pharmacy operators stock after selling 500 shares during the period. Mercer Capital Advisers []

Hedeker Wealth LLC cut its holdings in shares of CVS Health Co. (NYSE:CVS) by 10.5% during the third quarter, Holdings Channel.com reports. The institutional investor owned 45,977 shares of the pharmacy operators stock after selling 5,422 shares during the period. Hedeker Wealth LLCs holdings in CVS Health were worth $3,901,000 as of its most recent []

In the latest edition of STAT Health Tech: CVS leans into digital-first health, telehealth''s 2021 report card, and how cyberattacks could threaten clinical algorithms.

Ziegler Capital Management LLC decreased its position in shares of CVS Health Co. (NYSE:CVS) by 27.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 220,424 shares of the pharmacy operator’s stock after selling 81,849 shares during the period. CVS […]

Company Specific Highlights & Insights:BAH, BSX, CVS, GNRC, MO, PDCE, SWK, TWTR, TXN, URI Aggregate ECF Trend Analysis: Management confidence moderated significantly through 2021, after showing very bullish signals in the back half of 2020, coming out of the worst of the pandemic shutdown. Into August, the index appeared to be inflecting more negatively, though it has since reversed some in October. It remains Read More The post Valens Equity Weekly Insights and Inflections for December 14, 2021 appeared first on Valens Research .

CVS Health (NYSE:CVS) had its price objective lifted by Cowen from $103.00 to $114.00 in a research report released on Friday, The Fly reports. The brokerage currently has an outperform rating on the pharmacy operator’s stock. A number of other research analysts have also recently weighed in on the stock. Seaport Research Partners started coverage […] The post Cowen Boosts CVS Health (NYSE:CVS) Price Target to $114.00 appeared first on ETF Daily News .

CVS Health (NYSE:CVS) had its target price lifted by Mizuho from $105.00 to $110.00 in a research note published on Friday morning, The Fly reports. Mizuho currently has a buy rating on the pharmacy operator’s stock. Several other research firms also recently weighed in on CVS. Barclays lifted their target price on CVS Health from […]